XOMA Ltd. (XOMA:NASDAQ) Investor Relations Material

Overview

California-based XOMA Corporation serves as a biotech royalty aggregator across Europe, Asia Pacific and the United States. Their mission is to drive enhancements in human health by supporting biotech companies. With a strategic focus on early to mid-stage clinical assets, primarily in Phase 1 and 2 with commercial sales potential, XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology firms. The company boasts a diverse portfolio of assets and was founded in 1981.

Frequently Asked Questions

What is XOMA Ltd.'s ticker?

XOMA Ltd.'s ticker is XOMA

What exchange is XOMA Ltd. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are XOMA Ltd.'s headquarters?

They are based in EmeryVille, California

How many employees does XOMA Ltd. have?

There are 51-200 employees working at XOMA Ltd.

What is XOMA Ltd.'s website?

It is http://www.xoma.com/index.htm

What type of sector is XOMA Ltd.?

XOMA Ltd. is in the Healthcare sector

What type of industry is XOMA Ltd.?

XOMA Ltd. is in the Biotechnology industry

Who are XOMA Ltd.'s peers and competitors?

The following five companies are XOMA Ltd.'s industry peers:

- Silence Therapeutics plc

- Akari Therapeutics Plc

- HTG Molecular Diagnostics, Inc.

- Tiziana Life Sciences plc

- Amplia Therapeutics